202 related articles for article (PubMed ID: 18644400)
1. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
[TBL] [Abstract][Full Text] [Related]
2. Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations.
Gocek E; Kiełbiński M; Baurska H; Haus O; Kutner A; Marcinkowska E
Leuk Res; 2010 May; 34(5):649-57. PubMed ID: 19880182
[TBL] [Abstract][Full Text] [Related]
3. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
Collins ED; Bishop JE; Bula CM; Acevedo A; Okamura WH; Norman AW
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):279-88. PubMed ID: 15857747
[TBL] [Abstract][Full Text] [Related]
4. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
Peleg S; Ismail A; Uskokovic MR; Avnur Z
J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
Valrance ME; Welsh J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
[TBL] [Abstract][Full Text] [Related]
6. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
7. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis.
Bremmer F; Thelen P; Pottek T; Behnes CL; Radzun HJ; Schweyer S
Anticancer Res; 2012 Jan; 32(1):341-9. PubMed ID: 22213325
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
12. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
Garay E; Donnelly R; Wang X; Studzinski GP
J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
[TBL] [Abstract][Full Text] [Related]
13. Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells.
Marcinkowska E; Kutner A
Acta Biochim Pol; 2002; 49(2):393-406. PubMed ID: 12362981
[TBL] [Abstract][Full Text] [Related]
14. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
15. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
16. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
[TBL] [Abstract][Full Text] [Related]
17. 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor.
Sun X; Zemel MB
Int J Obes (Lond); 2008 Aug; 32(8):1305-11. PubMed ID: 18427562
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
[TBL] [Abstract][Full Text] [Related]
20. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation.
Gocek E; Marchwicka A; Baurska H; Chrobak A; Marcinkowska E
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):220-6. PubMed ID: 22789609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
